Abstract
AIM/BACKGROUND—The most common choice of treatment for choroidal haemangiomas (CH) in the past has been the employment of scatter photocoagulation of the surface. This management often requires repetitive treatment or additional invasive management due to massive exudative detachment of the retina. The aim of this retrospective study was to investigate the outcome of the alternative application of low dose external beam irradiation with high energetic photons on these tumours. METHODS—A total absorbed dose of 20 Gy was applied to a total of 51 symptomatic eyes: 36 with a circumscribed CH of the posterior pole and 15 with diffuse CH as part of the Sturge-Weber syndrome. The indication for treatment was an exudative retinal detachment including or threatening the fovea. The mean follow up times in each group were 4.5 and 5.3 years, respectively. Out of a group of 33 patients from whom reliable data could be derived, 17 had symptoms lasting longer than 6 months. RESULTS—In 23 cases (63.8%) with circumscribed CH complete resolution of the subretinal fluid was achieved; the remaining 13 cases (36.2%) showed residual serous detachment distant to the fovea. The visual acuity improved by two or more lines in 14 cases (38.9%), remained stable in 14 cases (38.9%), and decreased in eight cases (22.2%). The functional success was dependent on the lag duration between onset of first subjective symptoms and treatment. The morphological results with diffuse CH were similar to those of the group of circumscribed CH. The visual acuity (VA) at last examination was improved in seven cases (46.6%); in the remaining eight cases, VA was unchanged or had deteriorated. The poor functional outcome in the latter was mainly attributable to secondary glaucoma. CONCLUSION—External beam irradiation is a useful and a low invasive therapeutic option for CH. A successful functional outcome is dependent on the time delay between first onset of symptoms and the beginning of therapy, the formation of subretinal fibrosis, and also on secondary glaucoma in the case of Sturge-Weber syndrome.
Full Text
The Full Text of this article is available as a PDF (211.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anand R., Augsburger J. J., Shields J. A. Circumscribed choroidal hemangiomas. Arch Ophthalmol. 1989 Sep;107(9):1338–1342. doi: 10.1001/archopht.1989.01070020408045. [DOI] [PubMed] [Google Scholar]
- Greber H., Alberti W., Scherer E. Strahlentherapie der Aderhauthämangiome. Fortschr Ophthalmol. 1985;82(5):450–452. [PubMed] [Google Scholar]
- Greber H., Wessing A., Alberti W., Scherer E. Die erfolgreiche Behandlung eines Aderhauthämangioms mit Sekundärveränderungen bei Sturge-Weber-Syndrom. Klin Monbl Augenheilkd. 1984 Oct;185(4):276–278. doi: 10.1055/s-2008-1054614. [DOI] [PubMed] [Google Scholar]
- Humphrey W. T. Choroidal hemangioma: Response to cryotherapy. Ann Ophthalmol. 1979 Jan;11(1):100–104. [PubMed] [Google Scholar]
- JONES I. S., CLEASBY G. W. Hemangioma of the choroid: a clinicopathologic analysis. Am J Ophthalmol. 1959 Nov;48:612–628. doi: 10.1016/0002-9394(59)90452-0. [DOI] [PubMed] [Google Scholar]
- MACLEAN A. L., MAUMENEE A. E. Hemangioma of the choroid. Am J Ophthalmol. 1960 Jul;50:3–11. doi: 10.1016/0002-9394(60)90833-3. [DOI] [PubMed] [Google Scholar]
- MEYER-SCHWICKERATH G. Erfahrungen mit der Lichtkoagulation der Netzhaut und der Iris. Doc Ophthalmol. 1956;10:91-118; discussion, 119-31. [PubMed] [Google Scholar]
- Mackensen D., Meyer-Schwickerath G. Diagnostik und Therapie des Aderhauthämangioms. Klin Monbl Augenheilkd. 1980 Jul;177(1):16–23. doi: 10.1055/s-2008-1057604. [DOI] [PubMed] [Google Scholar]
- Messmer E. P., Sauerwein W., Heinrich T., Höpping W., Klueter-Reckmann D., Bornfeld N., Sack H., Förster M., Havers W. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol. 1990;228(5):426–431. doi: 10.1007/BF00927255. [DOI] [PubMed] [Google Scholar]
- Parsons J. T., Bova F. J., Fitzgerald C. R., Mendenhall W. M., Million R. R. Radiation retinopathy after external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):765–773. doi: 10.1016/0360-3016(94)90347-6. [DOI] [PubMed] [Google Scholar]
- Plowman P. N., Harnett A. N. Radiotherapy in benign orbital disease. I: Complicated ocular angiomas. Br J Ophthalmol. 1988 Apr;72(4):286–288. doi: 10.1136/bjo.72.4.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHEPENS C. L., SCHWARTZ A. Intraocular tumors. I. Bilateral hemangioma of the choroid. AMA Arch Ophthalmol. 1958 Jul;60(1):72–83. [PubMed] [Google Scholar]
- Sanborn G. E., Augsburger J. J., Shields J. A. Treatment of circumscribed choroidal hemangiomas. Ophthalmology. 1982 Dec;89(12):1374–1380. doi: 10.1016/s0161-6420(82)34635-7. [DOI] [PubMed] [Google Scholar]
- Scott T. A., Augsburger J. J., Brady L. W., Hernandez C., Woodleigh R. Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal detachment. Retina. 1991;11(4):389–393. doi: 10.1097/00006982-199111040-00004. [DOI] [PubMed] [Google Scholar]
- Shields J. A., Stephens R. F., Eagle R. C., Jr, Shields C. L., De Potter P. Progressive enlargement of a circumscribed choroidal hemangioma. A clinicopathologic correlation. Arch Ophthalmol. 1992 Sep;110(9):1276–1278. doi: 10.1001/archopht.1992.01080210094033. [DOI] [PubMed] [Google Scholar]
- Wessing A. Fluorescein-angiography and the differential diagnosis of choroidal tumors. Bull Soc Belge Ophtalmol. 1977;175:5–14. [PubMed] [Google Scholar]
- Witschel H., Font R. L. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol. 1976 May-Jun;20(6):415–431. doi: 10.1016/0039-6257(76)90067-9. [DOI] [PubMed] [Google Scholar]
- Zografos L., Bercher L., Chamot L., Gailloud C., Raimondi S., Egger E. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol. 1996 Feb;121(2):190–199. doi: 10.1016/s0002-9394(14)70584-7. [DOI] [PubMed] [Google Scholar]
